🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07625969
Recruiting Not applicable

Using Single and Combined Nudge Strategies to Promote Healthier Beverage Intake Among College Students

NCT07625969 · tracked via the Priya Life Science China tracker
Sponsor
Nanjing Medical University
Phase
Not applicable
Started
2026-07-02
Last updated
2026-07-07

Condition(s) studied

ObesityFood Selection

Investigational drug(s) / intervention(s)

choice architecturechoice architecturechoice architecture

choice architecture: Showing the various harms that can come from long-term excessive consumption of sugary beverages on the platform.

choice architecture: The platform shows the hedonic information about sugar-free beverages.

choice architecture: The platform shows both hedonic information about sugar-free beverages and information on the various harms of long-term excessive sugary beverage consumption.

Study summary

The primary objective of this study was to examine whether three nudging strategies influence beverage consumption behavior among Chinese university students. These interventions included health warning messages, hedonic labeling, and a combination of health warning and hedonic labeling. A between-subjects experimental design with a single factor was employed to assess the effects of these strategies on students' choices between sugar-sweetened and sugar-free beverages, thereby evaluating their effectiveness in promoting healthier beverage selections.

Eligibility

Sex
ALL
Min age
Max age
Healthy volunteers
Accepted
Inclusion Criteria: * college students * willing to participate Exclusion Criteria: none

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Nanjing Medical University Nanjing Jiangsu Recruiting

More Nanjing Medical University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07625969 on ClinicalTrials.gov ↗ ← All trials in China